Hiroaki Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroaki Tanaka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Chizuko Kamiya
Department of Perinatology National Cerebral and Cardiovascular Center Osaka Japan
3 shared publicationsJun Yoshimatsu
Department of Perinatology National Cerebral and Cardiovascular Center Osaka Japan
3 shared publicationsKayo Tanaka
Department of Perinatology National Cerebral and Cardiovascular Center Osaka Japan
3 shared publicationsNaoko Iwanaga
Department of Perinatology National Cerebral and Cardiovascular Center Osaka Japan
3 shared publicationsShinji Katsuragi
Department of Perinatology National Cerebral and Cardiovascular Center Osaka Japan
2 shared publicationsJun C. Takahashi
Department of Neurosugery National Cerebral and Cardiovascular Center Osaka Japan
1 shared publication
Latest Publications
- 27 October 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (4) , 517-522
Vaginal delivery in pregnancy with Moyamoya disease: Experience at a single institute
Aim: Cesarean section is commonly selected in pregnancy with Moyamoya disease. We consider vaginal delivery with epidural anesthesia a viable alternative in such cases.Methods: Mode of delivery and outcomes were examined in 27 pregnancies in 19 women with Moyamoya disease treated at the Department of Perinatology, National Cardiovascular Center, Japan, from 1983 to 2013. Of these 27 pregnancies, 20 were delivered vaginally with epidural anesthesia. The cerebral circulation, mode of delivery, maternal outcome (presence of symptoms due to Moyamoya disease intrapartum) and neonatal outcome (gestational week, birthweight, Apgar score at 5 min and pH of umbilical artery) were investigated.Results: The cerebral circulation was judged to be good in all pregnancies. No symptoms due to Moyamoya disease intrapartum were seen in the vaginal delivery cases.Conclusion: Our findings indicate that vaginal delivery is viable in pregnancy with Moyamoya disease and that unnecessary cesarean section may be avoided. These findings are limited by the retrospective nature of the study.
- 27 October 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (4) , 517-522
Vaginal delivery in pregnancy with Moyamoya disease: Experience at a single institute
Aim: Cesarean section is commonly selected in pregnancy with Moyamoya disease. We consider vaginal delivery with epidural anesthesia a viable alternative in such cases.Methods: Mode of delivery and outcomes were examined in 27 pregnancies in 19 women with Moyamoya disease treated at the Department of Perinatology, National Cardiovascular Center, Japan, from 1983 to 2013. Of these 27 pregnancies, 20 were delivered vaginally with epidural anesthesia. The cerebral circulation, mode of delivery, maternal outcome (presence of symptoms due to Moyamoya disease intrapartum) and neonatal outcome (gestational week, birthweight, Apgar score at 5 min and pH of umbilical artery) were investigated.Results: The cerebral circulation was judged to be good in all pregnancies. No symptoms due to Moyamoya disease intrapartum were seen in the vaginal delivery cases.Conclusion: Our findings indicate that vaginal delivery is viable in pregnancy with Moyamoya disease and that unnecessary cesarean section may be avoided. These findings are limited by the retrospective nature of the study.
- 2 September 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 40 (9) , 2031-2036
Analysis of pregnancies in women with Takayasu arteritis: Complication of Takayasu arteritis involving obstetric or cardiovascular events
Aims: The incidence of Takayasu arteritis during child‐bearing years is relatively high. The management of pregnancies in patients with this disease is of great importance in clinical obstetrics. Here we analyzed pregnancies of women with Takayasu arteritis with and without complications.Material and Methods: We retrospectively identified 27 pregnancies in 20 women with Takayasu arteritis seen between 1983 and 2005 at the National Cardiovascular Center, in Osaka, Japan. The incidences of obstetric events, steroid dose increase in pregnancy, and cardiovascular events were compared between group I (no complications), group II (one complication), and group III (two or more complications).Results: None of the pregnancies showed Takayasu arteritis activity. The obstetric events were pre‐eclampsia in four pregnancies (15%), fetal growth restriction in one (4%), and abruption in one (4%). Three pregnancies involved a steroids dose increase. There were no cardiovascular events. Eighty percent of the pregnancies that included an obstetric event also involved the mother's chronic hypertension.Conclusions: Pregnant women without active Takayasu arteritis have a low risk of developing a cardiovascular event. For women with chronic hypertension, it might be important to note the development of pre‐eclampsia, fetal growth restriction and abruption.
- 2 September 2014
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 40 (9) , 2031-2036
Analysis of pregnancies in women with Takayasu arteritis: Complication of Takayasu arteritis involving obstetric or cardiovascular events
Aims: The incidence of Takayasu arteritis during child‐bearing years is relatively high. The management of pregnancies in patients with this disease is of great importance in clinical obstetrics. Here we analyzed pregnancies of women with Takayasu arteritis with and without complications.Material and Methods: We retrospectively identified 27 pregnancies in 20 women with Takayasu arteritis seen between 1983 and 2005 at the National Cardiovascular Center, in Osaka, Japan. The incidences of obstetric events, steroid dose increase in pregnancy, and cardiovascular events were compared between group I (no complications), group II (one complication), and group III (two or more complications).Results: None of the pregnancies showed Takayasu arteritis activity. The obstetric events were pre‐eclampsia in four pregnancies (15%), fetal growth restriction in one (4%), and abruption in one (4%). Three pregnancies involved a steroids dose increase. There were no cardiovascular events. Eighty percent of the pregnancies that included an obstetric event also involved the mother's chronic hypertension.Conclusions: Pregnant women without active Takayasu arteritis have a low risk of developing a cardiovascular event. For women with chronic hypertension, it might be important to note the development of pre‐eclampsia, fetal growth restriction and abruption.
- Open Access
- 1 January 2014
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 78 (4) , 878-881
Analysis of Anticoagulant Therapy by Unfractionated Heparin During Pregnancy After Mechanical Valve Replacement
Background: Consensus has not been reached about the anticoagulant therapy to be used during pregnancy after mechanical valve replacement. Warfarin is a fetal toxicant, so we retrospectively examined anticoagulant therapy using unfractionated heparin. Methods and Results: Pregnancy after mechanical valve replacement occurred in 25 cases between 1983 and 2011. Targeted therapy using unfractionated heparin was administered in 9 pregnancies, which were divided into 3 groups: Group I received subcutaneous administration of heparin and APTT was measured twice weekly; Group II received heparin by constant rate infusion (CRI) and APTT was measured twice weekly; Group III received CRI of heparin and APTT was measured daily. Maternal complications consisted of valve thrombosis and perinatal bleeding in 1 pregnancy (Group I), intracranial hemorrhage in 2 pregnancies (Group II), and valve thrombosis and perinatal bleeding in 1 pregnancy (Group III). Two infants died in the neonatal period. Conclusions: Each group showed a high rate of maternal complications, so a review of current anticoagulant treatment strategies is necessary. (Circ J 2014; 78: 878–881)
- 1 January 2014
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 78 (4) , 878-881
Open AccessAnalysis of Anticoagulant Therapy by Unfractionated Heparin During Pregnancy After Mechanical Valve Replacement
Background: Consensus has not been reached about the anticoagulant therapy to be used during pregnancy after mechanical valve replacement. Warfarin is a fetal toxicant, so we retrospectively examined anticoagulant therapy using unfractionated heparin. Methods and Results: Pregnancy after mechanical valve replacement occurred in 25 cases between 1983 and 2011. Targeted therapy using unfractionated heparin was administered in 9 pregnancies, which were divided into 3 groups: Group I received subcutaneous administration of heparin and APTT was measured twice weekly; Group II received heparin by constant rate infusion (CRI) and APTT was measured twice weekly; Group III received CRI of heparin and APTT was measured daily. Maternal complications consisted of valve thrombosis and perinatal bleeding in 1 pregnancy (Group I), intracranial hemorrhage in 2 pregnancies (Group II), and valve thrombosis and perinatal bleeding in 1 pregnancy (Group III). Two infants died in the neonatal period. Conclusions: Each group showed a high rate of maternal complications, so a review of current anticoagulant treatment strategies is necessary. (Circ J 2014; 78: 878–881)